QuantHealth says its AI platform can predict results with 86% accuracy and support the success of faster, cheaper drug discovery and development

AION Labs, a consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company to build a computational platform to design live-saving antibodies from scratch

Human tests expected within a year; inventor says approach has potential for many viruses, including influenza, Zika, West Nile, and hepatitis B

Koch Disruptive Technologies, venture capital firm of Koch Industries, leads investment round

Tel Aviv-based startup uses machine learning to build computational models of human immune system and diseases to speed up treatments